Real world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from Grupo Argentino de Mieloma M últiple.

CONCLUSION: This is the first report of Rd combinations for the treatment of RRMM in Latin America. All combinations proved to be effective with an acceptable toxicity. PMID: 33541156 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33541156?dopt=Abstract

Source: Expert Review of Hematology - February 7, 2021 Category: Hematology Tags: Expert Rev Hematol Source Type: research